Treatment for Acute Postoperative Voiding Dysfunction (PTNS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
If patients are unable to have their foley catheter removed because their bladder is not emptying well, they may be eligible for study participation. This study is designed to evaluate whether Posterior Tibial Nerve Stimulation is effective in improving bladdder function after surgery. Study participation is limited to one day.
| Condition | Intervention |
|---|---|
|
Voiding Dysfunction |
Device: PTNS treatment Other: Sham treatment |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Acute Postoperative Voiding Dysfunction |
- Unsuccessful voiding trial [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]Persistence of unsuccessful voiding trial
- Voiding efficiency [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]Improvement of voiding efficiency
| Enrollment: | 84 |
| Study Start Date: | July 2006 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Sham Comparator: Sham treatment
No electrical stimulation is actually received
|
Other: Sham treatment
No electrical stimulation is given
|
|
Experimental: Peructaneous Tibial Nerve Stimulation
Patient receives PTNS for 30 minutes
|
Device: PTNS treatment
Electrical stimulation is received
|
Detailed Description:
If patients fail a voiding trial (the test done to see if a foley catheter is ready to be removed after surgery), they may be offered participation in this trial. Patients are randomized to receive active treatment or a sham treatment. A small, accupuncture-type needle is inserted through the skin just above the ankle. A small, battery-powered generator will be attached to the needle. The generator will give a low-voltabe stimulation which is adjusted for comfort level and applied for 30 minutes. After treatemnt, the voiding trial will be repeated.
Eligibility| Ages Eligible for Study: | 18 Years to 95 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- First voiding trial after Urogynecological surgery shows that bladder is not emptying well.
Exclusion Criteria:
- Patient declines participation.
Contacts and Locations| United States, Rhode Island | |
| Women & Infants Hospital of Rhode Island | |
| Providence, Rhode Island, United States, 02905 | |
| Principal Investigator: | Charles R Rardin, MD | Women and Infants Hospital |
More Information
No publications provided
| Responsible Party: | Charles Rardin, Principal Investigator, Women and Infants Hospital of Rhode Island |
| ClinicalTrials.gov Identifier: | NCT01189136 History of Changes |
| Other Study ID Numbers: | 06-0061, 06-0061 |
| Study First Received: | August 20, 2010 |
| Last Updated: | December 21, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Women and Infants Hospital of Rhode Island:
|
Voiding dysfunction |
ClinicalTrials.gov processed this record on May 22, 2013